Swiss Medica, Inc.
OTC Bulletin Board : SWME

Swiss Medica, Inc.

August 31, 2005 09:03 ET

Swiss Medica Selects Cone to Launch PMS Escape

TORONTO, ONTARIO--(CCNMatthews - Aug. 31, 2005) - Swiss Medica, Inc. (OTCBB:SWME) is pleased to announce that it has selected Cone, a Boston-based brand strategy and communications agency, for media relations, product launch support, and ongoing marketing communications around the launch of its PMS Escape product.

PMS Escape is a clinically tested, patented, all natural product to help women with premenstrual syndrome (PMS) related disturbances in mood and appetite. It is the first over the counter product available at retail to help women manage these disturbances and was developed by a leading nutritional biochemist, Judith Wurtman, Ph.D., a research scientist at MIT and the founder and director of Harvard University's TRIAD Weight Management Center.

Cone initially worked with PMS Escape when the product was test marketed. Cone conducted a comprehensive media relations campaign in support of the launch that resulted in explosive media coverage creating widespread awareness and demand for this product among thousands of women. To support the upcoming launch and reach women nationwide, Cone will conduct national and local market media relations, along with a word-of-mouth marketing campaign targeting key influencers such as physicians, nurses and registered dietitians.

"The test launch of PMS Escape was one of the most visible and successful consumer product launches in the history of the agency. We are thrilled to again be working with this important and life enhancing product," said Jens Bang, President and CEO of Cone, LLC. "This opportunity taps into our passion for consumer products and our vast experience in brand marketing."

"Selecting Cone to represent PMS Escape was a natural choice. Their deep understanding for the product, its target consumer, and their mastery of both traditional and cutting edge marketing communications tools elevated them to the top," said Wendy Kramer, Swiss Medica's Vice President. "The fact that Cone successfully handled the test launch of PMS Escape and possesses a strong familiarity with the product and space is merely a bonus."

About Cone

Founded in 1980, Cone is a nationally recognized and award-winning strategic brand and marketing communications agency dedicated to helping organizations build and maintain trusted relationships with their stakeholders and achieving a market leadership position through the power of its three competencies - by promoting an organization's products and services through its Brand Marketing Practice; by connecting corporations, nonprofits and social issues through its Cause Branding® Practice; and by helping organizations identify and manage risk to their reputation and mission as well as manage challenging issues that impact their organizations and/or industry through its Issues & Crisis Management Practice. Cone's client roster includes CVS/pharmacy, Starbucks, ConAgra Foods, Jiffy Lube, Perrier, Nestle Waters, Colombo, PetSafe, American Heart Association, Yoplait, Barbour and Jockey, among others. Cone is a member of the Omnicom Group.

About Swiss Medica Inc.

Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at, and

Swiss Medica's flagship product, the O24™ Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit, for ordering details and store locators for the nearest pharmacy.

Swiss Medica is launching the patented O24™ Fibromyalgia pain reliever (US Patent #6,444,238B1) over-the-counter in North American retailers in the fall of 2005. The National Fibromyalgia Association (NFA) recently awarded O24™ Fibromyalgia their first NFA Seal of Approval. Upwards of 11 million Americans suffer from the long-term pain associated with fibromyalgia. In a randomized double blind clinical trial, more than 90 per cent of the patients who used O24 Fibromyalgia™ reported mild to markedly better improvement, versus only 7 per cent who used the placebo. Customers can visit for information on O24 Fibromyalgia™ and to order the product online.

Swiss Medica also manufactures PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: for additional information and ordering details.

Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.

Contact Information

  • Swiss Medica, Inc.
    Investor Relations Contact:
    David Jones
    (866) 485-4243
    Cone Communications
    Public Relations Contact:
    Stephanie Doherty
    (617) 227-2111
    Stern & Co.
    Financial Media Contact: Stan Froelich
    VP, Media Relations
    (212) 888-0044